Follow us on:
Breaking News
September 2, 2026
CP Direct: Wednesday Edition
Breaking News
Adare_CP_Leaderboard_0926

Alteogen Signs $3.2B ALT-B4 Licensing Deal With Novartis

 
Alteogen Signs $3.2B ALT-B4 Licensing Deal With Novartis

Agreement gives Novartis options to develop subcutaneous formulations using Alteogen’s ALT-B4 platform.
Read More >>

Top Headlines

Breaking News

Rottendorf Pharma Begins €100M Oelde Campus Project

The Oelde campus is expected to expand annual tablet production capacity to up to 10 billion tablets.

SPONSOR

Boost Biosimilar Yields with Efficient-Pro Medium

See how Fresenius Kabi boosted titers, improved glycans, and reduced variants with Gibco Efficient-Pro Medium—ready for scale.

Breaking News
Collaborations & Alliances

Treeline, Roche Partner on TLN-121 Lymphoma Trial

Phase 1 study will evaluate TLN-121 with Roche’s glofitamab and mosunetuzumab in patients with B-cell lymphomas.

Breaking News
Collaborations & Alliances

Aurigene Signs Long-Term Manufacturing Deal With Global Pharma Company

The agreement covers commercial manufacturing and supply of 20+ sterile injectables, biologics and topical products across key global markets.

SPONSOR

Dear Sponsor, We Regret to Inform You...

Cell based assays keep showing up in FDA Complete Response Letters. Join Solvias experts on Sept 22 for a Contract Pharma webinar on the most common deficiencies and how to strengthen validation.

ThermoFisher_eBook_Steriles_0726_600x250

Breaking News
Collaborations & Alliances

AstraZeneca Completes License Agreement with Dizal for Lung Cancer Treatment Zegfrovy

AstraZeneca gets worldwide rights to development and commercialization, while paying Dizal $600 million up front.

Online Exclusives

Inside the Rapid Rise of iPSC Based Therapies

Nina Bauer of FUJIFILM Cellular Dynamics shares hands-on experience manufacturing iPSCs, their increasing importance, and the technical bottlenecks standing in their way. 

SPONSOR

[PODCAST] What's Behind Vetter's Global Expansion Push?

More capacity, broader capabilities, maintained quality. Vetter's Carsten Press discusses the investment strategy shaping the company's future and the value it delivers to injectable drug customers. Hear it on the Pharma Matters Podcast.

Featured Resources

Solution Center SPOTLIGHT

Formulated Solutions

Formulated Solutions is a leading North American CDMO, specializing in Rx, OTC, and medical devices. With 600+ experts and 800,000 sq. ft. across two sites, we develop, manufacture, and package topicals, nasal sprays, liquids, and aerosols. Our proprietary technologies power brands in 40+ countries, delivering innovation at scale since 1999.

 

Solution Center SPOTLIGHT

SGS North America, Inc.

SGS supports pharmaceutical and biopharmaceutical clients from development through commercialization with a comprehensive portfolio of expert-led GMP quality control and analytical testing services for raw materials, APIs, packaging components, and finished drug products. Our teams apply disciplined science and regulatory expertise across small and large molecule programs to support product characterization, comparability, stability, and final GMP product release.